Cel-Sci Common Stock

The latest common stock for CVM is $82M as of March 2026. That compares with $840M in the prior-year period — down 90.3% year over year. Investors often review this figure alongside Cel-Sci's historical trend and sector peers before judging valuation or financial health.

Over the past year, CVM's common stock moved from $840M to $82M — a 90.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cel-Sci's operating scale or balance-sheet position.

A common stock figure of $82M for CVM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CVM's common stock ($82M), review year-over-year change from $840M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cel-Sci's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.